AU2017235312A1 - Compositions, devices, and methods of fibromyalgia sensitivity testing - Google Patents

Compositions, devices, and methods of fibromyalgia sensitivity testing Download PDF

Info

Publication number
AU2017235312A1
AU2017235312A1 AU2017235312A AU2017235312A AU2017235312A1 AU 2017235312 A1 AU2017235312 A1 AU 2017235312A1 AU 2017235312 A AU2017235312 A AU 2017235312A AU 2017235312 A AU2017235312 A AU 2017235312A AU 2017235312 A1 AU2017235312 A1 AU 2017235312A1
Authority
AU
Australia
Prior art keywords
value
determined
average discriminatory
fibromyalgia
food preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017235312A
Other languages
English (en)
Inventor
Zackary IRANI-COHEN
Elisabeth LADERMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerica Inc
Original Assignee
Biomerica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerica Inc filed Critical Biomerica Inc
Publication of AU2017235312A1 publication Critical patent/AU2017235312A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/02—Nutritional disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
AU2017235312A 2016-03-15 2017-03-14 Compositions, devices, and methods of fibromyalgia sensitivity testing Abandoned AU2017235312A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662308348P 2016-03-15 2016-03-15
US62/308,348 2016-03-15
PCT/US2017/022349 WO2017160869A1 (en) 2016-03-15 2017-03-14 Compositions, devices, and methods of fibromyalgia sensitivity testing

Publications (1)

Publication Number Publication Date
AU2017235312A1 true AU2017235312A1 (en) 2018-10-04

Family

ID=59850607

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017235312A Abandoned AU2017235312A1 (en) 2016-03-15 2017-03-14 Compositions, devices, and methods of fibromyalgia sensitivity testing

Country Status (8)

Country Link
US (1) US20190145972A1 (https=)
EP (1) EP3430403A4 (https=)
JP (2) JP2019510226A (https=)
CN (1) CN109073648A (https=)
AU (1) AU2017235312A1 (https=)
CA (1) CA3056368A1 (https=)
MX (1) MX2018011166A (https=)
WO (1) WO2017160869A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102224649B1 (ko) 2014-11-14 2021-03-05 바이오메리카인코포레이티드 Ibs 민감도 테스트 구성, 장치 및 방법
WO2017160869A1 (en) * 2016-03-15 2017-09-21 Biomerica, Inc. Compositions, devices, and methods of fibromyalgia sensitivity testing
EP3497447B1 (en) 2016-07-08 2024-09-04 Biomerica, Inc. Compositions, devices, and methods of depression sensitivity testing
WO2022133467A1 (en) 2020-12-17 2022-06-23 Cummins Inc. Combustion cylinder end face components including thermal barrier coatings

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689569B2 (en) * 2001-08-14 2004-02-10 Immunosciences Lab., Inc. Saliva test for detection of food allergy, candidiasis, microflora imbalance, intestinal barrier dysfunction and humoral immunodeficiencies
GB0310522D0 (en) * 2003-05-08 2003-06-11 Yorktest Lab Ltd Assay panel
US7601509B2 (en) * 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type
CN101166760A (zh) * 2005-02-15 2008-04-23 阿波罗生命科学有限公司 分子及其嵌合分子
DE202006009206U1 (de) * 2006-03-14 2007-03-29 Bieger, Wilfried P., Priv.-Doz. Dr.med.habil. Testbestecks zur Bestimmung von neuroendokrinen gesundheitlichen Störungen
WO2009035529A1 (en) * 2007-09-10 2009-03-19 Immunohealth International, Llc Method of analysis, detection and correction of food intolerance in humans
WO2010056337A2 (en) * 2008-11-12 2010-05-20 Caris Mpi, Inc. Methods and systems of using exosomes for determining phenotypes
DK2429317T4 (da) * 2009-04-17 2019-05-13 Natac Pharma S L Sammensætninger med højt indhold af omega-3-fedtsyrer og med lavt indhold af phytansyre
GB201002601D0 (en) * 2010-02-16 2010-03-31 Microtest Matrices Ltd Allergen microarray
KR20130124487A (ko) * 2010-09-29 2013-11-14 유티아이 리미티드 파트너쉽 생체적합성, 생흡수성 나노구를 사용하는 자가면역 질병의 치료방법
EP2658561A4 (en) * 2010-12-03 2015-01-07 Sinil Pharmaceutical Co Ltd PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES COMPRISING A TRACHELOSPERMI CAULIS EXTRACT AND A PAEONIA SUFFRUTICOSA ANDREWS EXTRACT, AND PROCESS FOR PREPARING THE SAME
GB2490652A (en) * 2011-04-18 2012-11-14 Microtest Matrices Ltd Methods of quantifying antibodies, especially IgE antibodies in a sample
WO2013063366A2 (en) * 2011-10-27 2013-05-02 Stc.Unm Methods for screening viral like particles and identifying neutralizing epitopes and related vaccines, constructs, and libraries
EP2812028A4 (en) * 2012-02-07 2016-01-06 Jolla Inst Allergy Immunolog EPITOPES OF ALLERGENIC PROTEINS AND METHOD AND USE TO IMMUNE REACTION MODULATION
EP2657707A1 (en) * 2012-04-26 2013-10-30 B.R.A.H.M.S GmbH Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope
JP6285923B2 (ja) * 2012-06-22 2018-02-28 トラスティーズ・オブ・ダートマス・カレッジ 新規ＶＩＳＴＡ−Ｉｇコンストラクト及び自己免疫、アレルギー性及び炎症性障害の処置のためのＶＩＳＴＡ−Ｉｇの使用
CN202814976U (zh) * 2012-07-31 2013-03-20 白仲虎 一种用于食品不耐受性检测的检测组件
WO2014039718A1 (en) * 2012-09-05 2014-03-13 Arizona Board of Regents, a body Corporate of the State of Arizona, Acting for and on Behalf of Ariz Methods for discovering therapeutic targets
US20150292012A1 (en) * 2012-10-26 2015-10-15 Case Western Reserve University Biomarkers for nod2 and/or rip2 activity related application
WO2014182932A1 (en) * 2013-05-08 2014-11-13 The Board Of Trustees Of The Leland Stanford Junior University Methods of testing for allergen sensitivity
KR102224649B1 (ko) * 2014-11-14 2021-03-05 바이오메리카인코포레이티드 Ibs 민감도 테스트 구성, 장치 및 방법
WO2017160869A1 (en) * 2016-03-15 2017-09-21 Biomerica, Inc. Compositions, devices, and methods of fibromyalgia sensitivity testing

Also Published As

Publication number Publication date
EP3430403A4 (en) 2019-08-14
CA3056368A1 (en) 2017-09-21
MX2018011166A (es) 2019-03-28
JP2022022426A (ja) 2022-02-03
JP2019510226A (ja) 2019-04-11
CN109073648A (zh) 2018-12-21
WO2017160869A1 (en) 2017-09-21
EP3430403A1 (en) 2019-01-23
US20190145972A1 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
US20230417758A1 (en) Compositions, devices, and methods of ibs sensitivity testing
US20260072016A1 (en) Compositions, devices, and methods of osteoarthritis sensitivity testing
US20260110694A1 (en) Compositions, devices, and methods of psoriasis food sensitivity testing
US20250389730A1 (en) Compositions, devices, and methods of depression sensitivity testing
US20260036579A1 (en) Compositions, devices, and methods of functional dyspepsia sensitivity testing
US20260016486A1 (en) Compositions, devices, and methods of crohn's disease sensitivity testing
US20260049980A1 (en) Compositions, devices, and methods of attention deficit disorder/attention deficit hyperactivity disorder (add/adhd) sensitivity testing
US20260016469A1 (en) Compositions, devices, and methods of gastroesophageal reflux disease sensitivity testing
US20260072022A1 (en) Compositions, devices, and methods of migraine headache food sensitivity testing
US20190145972A1 (en) Compositions, devices, and methods of fibromyalgia sensitivity testing
US20190170767A1 (en) Compositions, devices, and methods of ulcerative colitis sensitivity testing
WO2018009845A1 (en) Compositions, devices, and methods of depression sensitivity testing
HK40067075A (en) Compositions, devices, and methods of ibs sensitivity testing

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application